Metabolic reprogramming and epigenetic modifications on the path to cancer

L Sun, H Zhang, P Gao - Protein & cell, 2022 - academic.oup.com
Metabolic rewiring and epigenetic remodeling, which are closely linked and reciprocally
regulate each other, are among the well-known cancer hallmarks. Recent evidence …

A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation

NC Williams, LAJ O'Neill - Frontiers in immunology, 2018 - frontiersin.org
Metabolism in immune cells is no longer thought of as merely a process for adenosine
triphosphate (ATP) production, biosynthesis, and catabolism. The reprogramming of …

[HTML][HTML] Tumour necrosis factor signalling in health and disease

J Holbrook, S Lara-Reyna, H Jarosz-Griffiths… - …, 2019 - ncbi.nlm.nih.gov
The master pro-inflammatory cytokine, tumour necrosis factor (TNF), has been shown to
modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a …

Coupling Krebs cycle metabolites to signalling in immunity and cancer

DG Ryan, MP Murphy, C Frezza, HA Prag… - Nature …, 2019 - nature.com
Metabolic reprogramming has become a key focus for both immunologists and cancer
biologists, with exciting advances providing new insights into the mechanisms underlying …

Metabolic modulation in macrophage effector function

C Diskin, EM Pålsson-McDermott - Frontiers in immunology, 2018 - frontiersin.org
Traditionally cellular respiration or metabolism has been viewed as catabolic and anabolic
pathways generating energy and biosynthetic precursors required for growth and general …

ACOD1 in immunometabolism and disease

R Wu, F Chen, N Wang, D Tang, R Kang - Cellular & molecular …, 2020 - nature.com
Immunometabolism plays a fundamental role in health and diseases and involves multiple
genes and signals. Aconitate decarboxylase 1 (ACOD1; also known as IRG1) is emerging …

Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection

S Nair, JP Huynh, V Lampropoulou… - Journal of Experimental …, 2018 - rupress.org
Immune-Responsive Gene 1 (Irg1) is a mitochondrial enzyme that produces itaconate under
inflammatory conditions, principally in cells of myeloid lineage. Cell culture studies suggest …

Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation

SW Ryter, AMK Choi - Translational Research, 2016 - Elsevier
The heme oxygenase-1 (HO-1) enzyme system remains an attractive therapeutic target for
the treatment of inflammatory conditions. HO-1, a cellular stress protein, serves a vital …

[HTML][HTML] The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases

X Shi, H Zhou, J Wei, W Mo, Q Li, X Lv - Redox biology, 2022 - Elsevier
Endogenous small molecules are metabolic regulators of cell function. Itaconate is a key
molecule that accumulates in cells when the Krebs cycle is disrupted. Itaconate is derived …

Itaconic acid exerts anti-inflammatory and antibacterial effects via promoting pentose phosphate pathway to produce ROS

X Zhu, Y Guo, Z Liu, J Yang, H Tang, Y Wang - Scientific reports, 2021 - nature.com
Itaconic acid is produced by immune responsive gene 1 (IRG1)-coded enzyme in activated
macrophages and known to play an important role in metabolism and immunity. In this study …